Author
Listed:
- Steven X. Cho
(Monash University
Hudson Institute of Medical Research
Hokkaido University Graduate School of Medicine)
- Ina Rudloff
(Monash University
Hudson Institute of Medical Research)
- Jason C. Lao
(Monash University
Hudson Institute of Medical Research)
- Merrin A. Pang
(Monash University
Hudson Institute of Medical Research)
- Rimma Goldberg
(Monash University
Hudson Institute of Medical Research
Monash University
Monash Health)
- Christine B. Bui
(Monash University
Hudson Institute of Medical Research)
- Catriona A. McLean
(Alfred Hospital
Monash University)
- Magdalena Stock
(ZIK Septomics, Jena University Hospital)
- Tilman E. Klassert
(ZIK Septomics, Jena University Hospital)
- Hortense Slevogt
(ZIK Septomics, Jena University Hospital)
- Niamh E. Mangan
(Monash University
Hudson Institute of Medical Research)
- Wei Cheng
(Beijing United Family Hospital
Capital Institute of Pediatrics)
- Doris Fischer
(Goethe University Hospital
St. Vincenz Hospital)
- Stefan Gfroerer
(Goethe University Hospital
Helios Clinic Berlin-Buch)
- Manjeet K. Sandhu
(Monash University
Hudson Institute of Medical Research
Monash Health)
- Devi Ngo
(Monash University
Hudson Institute of Medical Research)
- Alexander Bujotzek
(Roche Innovation Center Munich)
- Laurent Lariviere
(Roche Innovation Center Munich)
- Felix Schumacher
(Roche Innovation Center Munich)
- Georg Tiefenthaler
(Roche Innovation Center Munich)
- Friederike Beker
(University of Queensland
Neonatal Services, Mercy Hospital for Women)
- Clare Collins
(Neonatal Services, Mercy Hospital for Women
Joan Kirner Women’s & Children’s, Sunshine Hospital)
- C. Omar F. Kamlin
(Royal Women’s Hospital
University of Melbourne
Murdoch Children’s Research Institute)
- Kai König
(Medicum Wesemlin, Department of Paediatrics)
- Atul Malhotra
(Monash University
Hudson Institute of Medical Research
Monash Newborn, Monash Children’s Hospital)
- Kenneth Tan
(Monash University
Hudson Institute of Medical Research
Monash Newborn, Monash Children’s Hospital)
- Christiane Theda
(Royal Women’s Hospital
University of Melbourne
Murdoch Children’s Research Institute)
- Alex Veldman
(Hudson Institute of Medical Research
St. Vincenz Hospital
Liebig University Hospital)
- Andrew M. Ellisdon
(Monash University)
- James C. Whisstock
(Monash University
Monash University)
- Philip J. Berger
(Monash University
Hudson Institute of Medical Research)
- Claudia A. Nold-Petry
(Monash University
Hudson Institute of Medical Research)
- Marcel F. Nold
(Monash University
Hudson Institute of Medical Research
Monash Newborn, Monash Children’s Hospital)
Abstract
Necrotizing enterocolitis (NEC) is a severe, currently untreatable intestinal disease that predominantly affects preterm infants and is driven by poorly characterized inflammatory pathways. Here, human and murine NEC intestines exhibit an unexpected predominance of type 3/TH17 polarization. In murine NEC, pro-inflammatory type 3 NKp46−RORγt+Tbet+ innate lymphoid cells (ILC3) are 5-fold increased, whereas ILC1 and protective NKp46+RORγt+ ILC3 are obliterated. Both species exhibit dysregulation of intestinal TLR repertoires, with TLR4 and TLR8 increased, but TLR5-7 and TLR9-12 reduced. Transgenic IL-37 effectively protects mice from intestinal injury and mortality, whilst exogenous IL-37 is only modestly efficacious. Mechanistically, IL-37 favorably modulates immune homeostasis, TLR repertoires and microbial diversity. Moreover, IL-37 and its receptor IL-1R8 are reduced in human NEC epithelia, and IL-37 is lower in blood monocytes from infants with NEC and/or lower birthweight. Our results on NEC pathomechanisms thus implicate type 3 cytokines, TLRs and IL-37 as potential targets for novel NEC therapies.
Suggested Citation
Steven X. Cho & Ina Rudloff & Jason C. Lao & Merrin A. Pang & Rimma Goldberg & Christine B. Bui & Catriona A. McLean & Magdalena Stock & Tilman E. Klassert & Hortense Slevogt & Niamh E. Mangan & Wei C, 2020.
"Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities,"
Nature Communications, Nature, vol. 11(1), pages 1-19, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-19400-w
DOI: 10.1038/s41467-020-19400-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-19400-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.